QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $372,938 |
| Gross Profit | $0 | $0 | $0 | -$372,938 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $0 | $4 | $10 | $1 |
| SG&A Expenses | $3 | $4 | $10 | $1 |
| Sales & Mktg Exp. | -$1,780,810 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$3 |
| Operating Expenses | $4 | $5 | $11 | $1 |
| Operating Income | -$4 | -$5 | -$11 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$1 | -$4 |
| Pre-Tax Income | -$4 | -$5 | -$12 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$6 | -$13 | -$5 |
| % Margin | – | – | – | – |
| EPS | -1.24 | -3.45 | -16.13 | -19.57 |
| % Growth | 64.1% | 78.6% | 17.6% | – |
| EPS Diluted | -1.24 | -3.45 | -16.13 | -19.57 |
| Weighted Avg Shares Out | 4 | 2 | 1 | 0 |
| Weighted Avg Shares Out Dil | 4 | 2 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $36,300 | $0 | $0 | -$3 |
| EBITDA | $36,296 | -$5 | -$12 | -$5 |
| % Margin | – | – | – | – |